Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma

BACKGROUND: Malignant pleural mesothelioma (MPM) is rare and aggressive neoplasia, with a poor prognosis; furthermore, the monetary cost of its treatment represents a major challenge for many patients. The economic burden this malignancy imposes is underscored by the fact that asbestos exposure, whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Arrieta, Oscar, Muñoz-Montaño, Wendy, Muñiz-Hernández, Sae, Campos, Saul, Catalán, Rodrigo, Soto-Molina, Herman, Guzmán Vázquez, Silvia, Díaz-Álvarez, Osvaldo, Martínez-Pacheco, Victor, Turcott, Jenny G., Ramos-Ramírez, Maritza, Cabrera-Miranda, Luis, Barrón, Feliciano, Cardona, Andrés F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095245/
https://www.ncbi.nlm.nih.gov/pubmed/33959504
http://dx.doi.org/10.3389/fonc.2021.641975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095245/
https://www.ncbi.nlm.nih.gov/pubmed/33959504
http://dx.doi.org/10.3389/fonc.2021.641975

Ejemplares similares